Publications en collaboration avec des chercheurs de Hospital General Universitario de Alicante (18)

2023

  1. The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants

    Orphanet journal of rare diseases, Vol. 18, Núm. 1, pp. 8

2022

  1. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198

  2. Natural History of MYH7-Related Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461

  3. Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study

    Revista Espanola de Cardiologia, Vol. 75, Núm. 7, pp. 559-567

2021

  1. Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 78, Núm. 17, pp. 1682-1699

2020

  1. Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis

    Journal of the American College of Cardiology, Vol. 76, Núm. 2, pp. 186-197

2018

  1. Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2457-2467

2017

  1. Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation

    International Journal of Cardiology, Vol. 248, pp. 232-238

2016

  1. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies

    Journal of the American College of Cardiology, Vol. 68, Núm. 22, pp. 2440-2451

2013

  1. A study of the SCN5A gene in a cohort of 76 patients with Brugada syndrome

    Clinical Genetics, Vol. 83, Núm. 6, pp. 530-538

2009

  1. Miocardiopatía hipertrófica. Estudio del gen de la troponina T en 127 familias españolas

    Revista Espanola de Cardiologia, Vol. 62, Núm. 12, pp. 1473-1477

2008

  1. Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation. Implications for Bleeding Risk and Prognosis

    Journal of the American College of Cardiology, Vol. 51, Núm. 8, pp. 818-825

  2. Cardiorresonancia magnética con gadolinio y capacidad de esfuerzo en la miocardiopatía hipertrófica

    Revista Espanola de Cardiologia, Vol. 61, Núm. 8, pp. 853-860

  3. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy

    American Heart Journal, Vol. 156, Núm. 1, pp. 85-91

  4. Variables Associated With Contrast-Enhanced Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy: Clinical Implications

    Journal of Cardiac Failure, Vol. 14, Núm. 5, pp. 414-419

2007

  1. Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 50, Núm. 25, pp. 2399-2403

  2. Respuesta

    Revista Espanola de Cardiologia

2006

  1. Desfibrilador automático en la miocardiopatía hipertrófica. Experiencia de 3 centros

    Revista Espanola de Cardiologia, Vol. 59, Núm. 6, pp. 537-544